More than 300 delegates will gather in Croke Park, Dublin, this month for ‘Innovate for Life’, the IPHA Annual Conference and Dinner which is set to make a big statement about the future for medicines innovation.
The event will draw record numbers across industry, policy, patient advocacy, research and academia for lively discussions on the major themes shaping the biopharmaceutical industry in Ireland and globally.
The line-up of keynoters and contributors is high-calibre – 24 cross-sector thought-leaders, 46% of whom are women, will share their views on everything from the therapies of the future to value-based adoption of medicines, from industry-academic-Government partnerships to patients’ experience of managing illness, and from data in healthcare to best practice in self-care.
In the morning, the Minister for Health, Simon Harris, will deliver a message to the conference. He will be followed by keynotes from Pierre Meulien, Executive Director of the Innovative Medicines Initiative and Gwynne Morley, General Manager at IQVIA who, respectively, will deal with public-private partnerships in new medicines development and the pipeline for innovative therapies.
Two fora will, consecutively, examine the digital health and consumer health landscapes, with thought-leaders from industry and the public sector. Then, the Learning Lab, a panel, powered by EY which is a new conference sponsor this year, will gather domestic and international experts to explore next-generation therapies and why they should be adopted by the health services.
A panel called The Patients’ Experience will hear first-hand what it’s like to use the health services and how medicines can help improve quality of life.
The moderator for the day is Virgin Media News’ Colette Fitzpatrick.
In the evening, Paul Reid, the HSE’s Director General, will keynote. We will debut our ‘Innovate For Life’ long-form documentary. Cutdowns of the film are already live on IPHA’s social channels.
Bernard Mallee, IPHA’s Director of Communications and Advocacy, said the event was aimed at making a bold statement about the impact and promise of medicines innovation.
“This is about having the best speakers, using the best technology and sharing the best content to tell an exciting story for an industry whose lifeblood is innovation. We are doing this for the people who work in the industry, for the policymakers who create the environment for medicines innovation and for the patients who rely on treatments to help them through illness,” said Mr Mallee.